$0.60 EPS Expected for TriMas Co. (NASDAQ:TRS) This Quarter

Wall Street analysts predict that TriMas Co. (NASDAQ:TRS) will post earnings of $0.60 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for TriMas’ earnings. The highest EPS estimate is $0.62 and the lowest is $0.58. TriMas reported earnings of $0.43 per share in the same quarter last year, which would indicate a positive year over year growth rate of 39.5%. The firm is scheduled to report its next quarterly earnings results before the market opens on Thursday, October 28th.

On average, analysts expect that TriMas will report full-year earnings of $2.30 per share for the current fiscal year, with EPS estimates ranging from $2.25 to $2.35. For the next financial year, analysts forecast that the company will post earnings of $2.63 per share, with EPS estimates ranging from $2.51 to $2.75. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that cover TriMas.

TriMas (NASDAQ:TRS) last announced its quarterly earnings results on Wednesday, July 28th. The industrial products company reported $0.62 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.55 by $0.07. The company had revenue of $218.99 million during the quarter, compared to the consensus estimate of $223.83 million. TriMas had a negative net margin of 6.43% and a positive return on equity of 12.88%.

Separately, Zacks Investment Research cut TriMas from a “buy” rating to a “hold” rating and set a $35.00 target price for the company. in a research report on Wednesday, June 30th.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TRS. Bbva USA bought a new stake in shares of TriMas in the 2nd quarter valued at approximately $30,000. Berman Capital Advisors LLC lifted its stake in shares of TriMas by 51.3% during the 3rd quarter. Berman Capital Advisors LLC now owns 1,024 shares of the industrial products company’s stock worth $33,000 after acquiring an additional 347 shares during the last quarter. Federated Hermes Inc. lifted its stake in shares of TriMas by 122.8% during the 1st quarter. Federated Hermes Inc. now owns 3,164 shares of the industrial products company’s stock worth $96,000 after acquiring an additional 1,744 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of TriMas by 22.2% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 4,761 shares of the industrial products company’s stock worth $144,000 after buying an additional 866 shares during the period. Finally, Jump Financial LLC bought a new position in TriMas during the 2nd quarter worth about $210,000. Institutional investors and hedge funds own 97.45% of the company’s stock.

TRS stock opened at $31.64 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.95 and a current ratio of 3.02. TriMas has a fifty-two week low of $22.82 and a fifty-two week high of $36.62. The business’s 50-day moving average is $31.30 and its two-hundred day moving average is $31.33. The company has a market cap of $1.36 billion, a price-to-earnings ratio of -26.15 and a beta of 0.76.

TriMas Company Profile

TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. It operates through the following segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs and manufactures dispensing products, (including foaming pumps, lotion and hand soap pumps, sanitizer pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers), polymeric and steel caps and closures (including food lids, flip-top closures, child resistance caps, drum and pail closures and flexible spouts), polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, all for a variety of consumer product markets including, but not limited to beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical, as well as the industrial market.

Read More: How is net asset value different from market price?

Get a free copy of the Zacks research report on TriMas (TRS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.